FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

30993311000001109: Timolol 10mg / Bendroflumethiazide 2.5mg tablets (Viatris UK Healthcare Ltd) (product)


Status: current, Not sufficiently defined by necessary conditions definition status. Date: 09-Dec 2015. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
2109001000001119 Timolol 10mg / Bendroflumethiazide 2.5mg tablets (Viatris UK Healthcare Ltd) en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
2109021000001114 Timolol 10mg / Bendroflumethiazide 2.5mg tablets (Viatris UK Healthcare Ltd) (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module


0 descendants.

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Timolol 10mg / Bendroflumethiazide 2.5mg tablets (Viatris UK Healthcare Ltd) Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Timolol 10mg / Bendroflumethiazide 2.5mg tablets (Viatris UK Healthcare Ltd) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none true Inferred relationship Existential restriction modifier
Timolol 10mg / Bendroflumethiazide 2.5mg tablets (Viatris UK Healthcare Ltd) Is a Product containing precisely bendroflumethiazide 2.5 milligram and timolol maleate 10 milligram/1 each conventional release oral tablet true Inferred relationship Existential restriction modifier
Timolol 10mg / Bendroflumethiazide 2.5mg tablets (Viatris UK Healthcare Ltd) Has active ingredient Bendroflumethiazide false Inferred relationship Existential restriction modifier
Timolol 10mg / Bendroflumethiazide 2.5mg tablets (Viatris UK Healthcare Ltd) Has active ingredient Timolol maleate false Inferred relationship Existential restriction modifier
Timolol 10mg / Bendroflumethiazide 2.5mg tablets (Viatris UK Healthcare Ltd) Has manufactured dose form Conventional release oral tablet true Inferred relationship Existential restriction modifier
Timolol 10mg / Bendroflumethiazide 2.5mg tablets (Viatris UK Healthcare Ltd) VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Timolol 10mg / Bendroflumethiazide 2.5mg tablets (Viatris UK Healthcare Ltd) VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Timolol 10mg / Bendroflumethiazide 2.5mg tablets (Viatris UK Healthcare Ltd) Has specific active ingredient Bendroflumethiazide true Inferred relationship Existential restriction modifier
Timolol 10mg / Bendroflumethiazide 2.5mg tablets (Viatris UK Healthcare Ltd) Has specific active ingredient Timolol maleate true Inferred relationship Existential restriction modifier
Timolol 10mg / Bendroflumethiazide 2.5mg tablets (Viatris UK Healthcare Ltd) Has dispensed dose form Tablet true Inferred relationship Existential restriction modifier
Timolol 10mg / Bendroflumethiazide 2.5mg tablets (Viatris UK Healthcare Ltd) Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Timolol 10mg / Bendroflumethiazide 2.5mg tablets (Viatris UK Healthcare Ltd) Is a Actual medicinal product true Inferred relationship Existential restriction modifier

Inbound Relationships Type Active Source Characteristic Refinability Group
Timolol 10mg / Bendroflumethiazide 2.5mg tablets (Viatris UK Healthcare Ltd) 30 tablet Has AMP True Timolol 10mg / Bendroflumethiazide 2.5mg tablets (Viatris UK Healthcare Ltd) Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start